期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | CLINICAL AND EXPERIMENTAL HYPERTENSION LetPub Score 5.2
50 ratings
Rate
Reputation 6.4 Influence 3.8 Speed 7.0 | ||||||||||||||||||||
期刊簡稱 | CLIN EXP HYPERTENS | ||||||||||||||||||||
ISSN | 1064-1963 | ||||||||||||||||||||
E-ISSN | 1525-6006 | ||||||||||||||||||||
h-index | 45 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 6.70%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://informahealthcare.com/journal/ceh | ||||||||||||||||||||
在線稿件提交 | http://mc.manuscriptcentral.com/lceh | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | Informa Healthcare | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||||||
創刊年 | 1993 | ||||||||||||||||||||
每年文章數 | 77每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 37.12% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1064-1963%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Slow, 6-12 Week(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: Easy | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 下一頁 末頁 (頁 | |
[CLINICAL AND EXPERIMENTAL HYPERTENSION] 的評論 | 撰寫評論 |
作者: 千斤青枫 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-04 19:10:05 評論於 Review speed: 3.0 | Submission success rate: 50.0 Experience sharing: ... hoping to receive.(0) 讚! | 千斤青枫 |
作者: 辉夜芳蕤 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-19 16:15:55 評論於 Just checked on the WOS official website(0) 讚! | 辉夜芳蕤 |
作者: 辉夜芳蕤 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-19 11:29:57 評論於 The other plugins have also been updated... everything has been restored(0) 讚! | 辉夜芳蕤 |
作者: 缠丝志煜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-30 22:18:32 評論於 Please translate the following passage into English and Japanese, and use ":" and ":" as headings: Urgent help needed(0) 讚! | 缠丝志煜 |
作者: 缠丝志煜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-30 11:02:12 評論於 Are you sure? How did you check?(0) 讚! | 缠丝志煜 |
作者: 缠丝志煜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-30 08:21:49 評論於 The reunion is approaching, and I don't know what to do now(0) 讚! | 缠丝志煜 |
作者: 辉夜芳蕤 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-26 10:29:39 評論於 It's 2.6, WOS has been updated.. Other plugins have not been updated yet(0) 讚! | 辉夜芳蕤 |
作者: 北马元洲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-16 14:18:14 評論於 Review speed: 2.0 | Submission acceptance rate: 75.0 Feedback sharing: Submitted at the beginning of January, received minor revisions in mid-March, accepted after 5 days of revisions, and published online in early April. The efficiency is very good. The reviewer's comments were quite fair, without deliberately causing difficulties. Now we need to pay the publication fee!(0) 讚! | 北马元洲 |
作者: 帅红来了 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-13 17:34:32 評論於 Just received a paper, haven't paid the page charges yet, checked on Web of Science, impact factor is 2.6, while other platforms show 12.3. Does anyone know what's going on?(0) 讚! | 帅红来了 |
作者: 墟散清安 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-21 16:06:47 評論於 Review speed: 6.0 | Submission acceptance rate: 50.0 Focused research direction: Clinical hypertension; Hypertension experience sharing: I have been researching hypertension for 22 years. How come I only received 2 points for my submission last time, but now I suddenly received over 12 points this year? ?(0) 讚! | 墟散清安 |
作者: 珉林惜风 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-29 09:30:18 評論於 Heavy research direction: Hypertension Experience sharing: Is the current period fast?(0) 讚! | 珉林惜风 |
作者: 京城斐然 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-19 13:46:15 評論於 Please translate the following passage into English and Japanese, and use ":" as the heading(0) 讚! | 京城斐然 |
作者: 巴蜀向真 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-10 13:54:22 評論於 Why did it suddenly rise so high, can it be sustained?(0) 讚! | 巴蜀向真 |
作者: Ralap Joule 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-05 23:43:15 評論於 "Review speed: 3.0 Emphasis on research direction: hypertension Experience sharing: From two points, it soared to 12 points in one go, a local chicken turned into a phoenix. The comrades who submitted last year must be laughing their heads off."(0) 讚! | Ralap Joule |
作者: 排云栾诺 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-21 21:17:49 評論於 No, maybe you chose color printing(0) 讚! | 排云栾诺 |
作者: 兰花松浩 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-16 16:42:02 評論於 Do I not need a layout fee, then why do I have to submit?(0) 讚! | 兰花松浩 |
作者: 排云栾诺 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-31 18:08:45 評論於 Review speed: 3.0 | Submission hit rate: 75.0 Research focus: Clinical direction of hypertension; sharing experience on hypertension: The impact factor for the new year is just over 2, increased slightly. Submitted a meta-analysis of the integrated treatment of hypertension with traditional Chinese and Western medicine, which I felt was written very simply. The initial review and external review took a total of three months, urged once, with only one reviewer. The reviewer's feedback was very positive, with minimal revisions. However, the review process was very slow, it felt like the feedback came back early but was not processed continuously, with no need for publication fee(0) 讚! | 排云栾诺 |
作者: 先天优扬 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-14 13:13:16 評論於 How are you doing now?(0) 讚! | 先天优扬 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 14:30:48 評論於 The corresponding author is the overall leader of the project, responsible for the project's funding, design, writing of articles, and quality control. They are also responsible for communicating with the journal during submission, peer review, and the entire publication process(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 14:22:59 評論於 The corresponding author of a SCI journal paper does not necessarily have to be only one person. There is no fixed standard on the specific number of corresponding authors because different SCI journals have different policies on the number of corresponding authors. For SCI journals that only accept one corresponding author, if the paper lists multiple corresponding authors, the first corresponding author listed will be automatically selected as the corresponding author. For SCI journals that accept two corresponding authors, two corresponding authors can be listed. The same principle applies to other requirements - the number of corresponding authors listed by the authors must comply with the regulations of the target SCI journal. The first author of a SCI paper is the person who has made the greatest contribution to the experiment and writing of the article, and is the person listed first in the author column. However, in collaborative works, it is common to have co-first authors. There is no clear rule on the number of co-first authors, and it greatly depends on the workload, length of the paper, publication guidelines, and recognition of the institution. In general, a SCI paper can have 2-4 first authors(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 北国博达 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 23:40:05 評論於 What is the corresponding author?(0) 讚! | 北国博达 |
作者: 破戒阳平 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 16:43:39 評論於 How many corresponding authors/ first authors can a journal have?(0) 讚! | 破戒阳平 |
作者: Elmer Lindsay 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-17 13:57:25 評論於 It's been five months and still no results, it's over, asking is useless!(0) 讚! | Elmer Lindsay |
作者: Elmer Lindsay 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-09-04 22:36:12 評論於 Where do online authors come from?(0) 讚! | Elmer Lindsay |
作者: Elmer Lindsay 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-09-04 17:25:03 評論於 Where is the table?(0) 讚! | Elmer Lindsay |
首頁 上一頁 1 2 3 下一頁 末頁 (頁 |
Contact us